Welcome to the Dana-Farber/Harvard Cancer Center web site. DF/HCC is the largest comprehensive cancer center in the nation, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
DF/HCC takes a unified approach to approving, activating, monitoring, and supporting the cancer-related clinical trials conducted at member institutions. Annually, the Center conducts approximately 500 active therapeutic clinical trials, many at multiple DF/HCC member sites. You are able to search clinical trials by diagnosis or by keywords to obtain preliminary eligibility criteria, participating DF/HCC institution(s), and trial contact information.